Health Care & Life Sciences » Biotechnology | Shanghai Hile Bio-Technology Co. Ltd.

Shanghai Hile Bio-Technology Co. Ltd. A | Mutual Funds

Mutual Funds that own Shanghai Hile Bio-Technology Co. Ltd. A

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
11,728,429
1.82%
-3,311,702
4.01%
12/31/2017
Fund Kexun
5,394,658
0.84%
5,394,658
1.03%
12/31/2017
849,483
0.13%
849,483
0.26%
12/31/2017
539,698
0.08%
539,698
1.12%
12/31/2017
480,400
0.08%
480,400
0.04%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
433,341
0.07%
0
0%
07/31/2018
220,215
0.03%
-208,970
0.18%
12/31/2017
195,420
0.03%
19,000
0.17%
12/31/2017
83,600
0.01%
83,600
0.35%
12/31/2017
Fund Kerui
40,000
0.01%
40,000
0.01%
12/31/2016

About Shanghai Hile Bio-Technology Co.

View Profile
Address
No. 6720 Jinhai Road
Shanghai Shanghai 201403
China
Employees -
Website http://www.hile-bio.com
Updated 07/08/2019
Shanghai Hile Bio-Technology Co., Ltd. engages in the manufacture and sale of veterinary vaccine and inactivated vaccine. It specializes in pig, poultry, and pet vaccine products. It offers inactivated rabies vaccines, avian infectious bronchitis vaccine, swine fever vaccine, porcine transmissible gastroenteritis and porcine epidemic diarrhea bivalent inactivated vaccine, highly pathogenic blue ear pig disease vaccine, porcine reproductive and respiratory syndrome vaccine, and porcine circovirus type 2 inactivated vaccine.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.